EBS Emergent BioSolutions crushes EPS estimates by 183 but faces revenue headwinds with 30 annual decline shares edge higher What NBT Bancorp NBTB disclosed about workforce costs Q1 2026 Earnings Underperform SPDR SP Semiconductor ETF XSD A Diversified Alternative to Concentrated CapWeighted Semiconductor Exposure Salesforce Inc CRM UK Regulated Sector AI Adoption Tailwinds Amid Material Valuation Dislocation Global X FinTech ETF FINX YTD Underperformance Highlights Diverging Dynamics Across Digital Economy Thematic ETFs Amid Rate Volatility What Southern SOJE auditor changes mean for investors Q1 2026 Better Than Expected RLMD Relmada Therapeutics sinks 55 on 103 EPS miss cash runway concerns intensify for biotech firm The moat Sagimet SGMT is building for long term dominance 855 20260506